The US 10-year Treasury yield has surpassed 5%, a level not seen since before the 2008 financial crisis, as markets anticipate a Federal Reserve rate hike. Economist David Rosenberg warns that the real risk lies in multiple hikes priced in by the market, which may not be justified by the underlying economic data. He highlights discrepancies in inflation and job reports and points to rising energy costs as a cost squeeze rather than inflation driven by demand. The Fed is expected to raise rates by 0.25%, but Rosenberg cautions that further hikes could strain the economy. Investors are watching the Fed's signals closely, with bond yields offering attractive returns amid uncertainty.
The US 10-year Treasury yield surpassing 5% marks a significant level not seen since before the 2008 financial crisis. For readers following this, here is Pluang's market snapshot as of Sep 15, 2026 21:57 WIB: out of 150 priced US stocks tradable on Pluang, 37 rose and 111 fell today. Notable movers include CVNA (Carvana Co) down 3.87%, HPE (Hewlett Packard Enterprise Co) up 3.68%, and QCOM (QUALCOMM, Inc.) up 3.62%.
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
Comcast announced a strategic restructuring to separate its connectivity and technology division from its media operations, including NBCUniversal and Sky. UBS raised Comcast's price target to $27, suggesting a 10% upside from current prices. The com...
